GlaxoSmithKline plc (GSK) Rating Reiterated by Deutsche Bank AG
GlaxoSmithKline plc (LON:GSK)‘s stock had its “hold” rating restated by Deutsche Bank AG in a note issued to investors on Wednesday. They presently have a GBX 1,870 ($23.14) target price on the stock. Deutsche Bank AG’s target price would suggest a potential upside of 8.78% from the stock’s previous close.
A number of other equities research analysts have also recently commented on the stock. Shore Capital reiterated a “hold” rating on shares of GlaxoSmithKline plc in a report on Wednesday, July 27th. JPMorgan Chase & Co. increased their price target on shares of GlaxoSmithKline plc from GBX 1,470 ($18.19) to GBX 1,800 ($22.28) and gave the company a “neutral” rating in a report on Tuesday, July 12th. BNP Paribas reiterated a “neutral” rating and set a GBX 1,430 ($17.70) price target on shares of GlaxoSmithKline plc in a report on Sunday, July 3rd. Goldman Sachs Group Inc. reiterated a “buy” rating and set a GBX 1,800 ($22.28) price target on shares of GlaxoSmithKline plc in a report on Tuesday, July 12th. Finally, Morgan Stanley increased their price target on shares of GlaxoSmithKline plc from GBX 1,500 ($18.56) to GBX 1,650 ($20.42) and gave the company an “equal weight” rating in a report on Monday, July 11th. Three equities research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and eight have assigned a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus target price of GBX 1,685.04 ($20.85).
GlaxoSmithKline plc (LON:GSK) opened at 1709.50 on Wednesday. The firm’s market cap is GBX 83.10 billion. GlaxoSmithKline plc has a 1-year low of GBX 1,277.25 and a 1-year high of GBX 1,745.56. The firm’s 50-day moving average price is GBX 1,647.81 and its 200-day moving average price is GBX 1,559.14.
This story is the sole property of American Banking News and it was originally published by American Banking News. If you are reading this story on another website, that means this article was illegally copied and re-published to this website in violation of U.S. and International copyright law. The original version of this article is available at https://www.americanbankingnews.com/2016/10/12/glaxosmithkline-plc-gsk-given-a-gbx-1870-price-target-at-deutsche-bank-ag.html
The business also recently declared a dividend, which will be paid on Thursday, October 13th. Shareholders of record on Thursday, August 11th will be issued a GBX 19 ($0.24) dividend. The ex-dividend date is Thursday, August 11th. This represents a yield of 1.12%.
In other GlaxoSmithKline plc news, insider Witty,Sir Andrew P sold 10,000 shares of GlaxoSmithKline plc stock in a transaction on Wednesday, July 27th. The shares were sold at an average price of GBX 1,693 ($20.95), for a total value of £169,300 ($209,529.70). Also, insider Slaoui,Moncef acquired 28 shares of the company’s stock in a transaction on Friday, August 12th. The stock was acquired at an average cost of GBX 2,208 ($27.33) per share, with a total value of £618.24 ($765.15).
About GlaxoSmithKline plc
GlaxoSmithKline plc (GSK) is a healthcare company. The Company is engaged in the creation and discovery, development, manufacture and marketing of pharmaceutical products, including vaccines, over-the-counter (OTC) medicines and health-related consumer products. The Company’s segments include Pharmaceuticals, Pharmaceuticals R&D, Vaccines and Consumer Healthcare.
Receive News & Ratings for GlaxoSmithKline plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GlaxoSmithKline plc and related companies with MarketBeat.com's FREE daily email newsletter.